Bellevue Group Ag Trans Medics Group, Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 169,844 shares of TMDX stock, worth $13.7 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

169,844

Previous 201,415 15.67%

Holding current value

$13.7 Million

Previous $30.3 Million 12.1%

% of portfolio

0.45%

Previous 0.51%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$135.68 - $176.11 $4.28 Million - $5.56 Million	-31,571 Reduced 15.67%	169,844 $26.7 Million
Q2 2024 Aug 14, 2024	SELL	$72.62 - $150.62 $11.8 Million - $24.5 Million	-162,649 Reduced 44.68%	201,415 $30.3 Million
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $11 Million - $13.9 Million	-154,826 Reduced 29.84%	364,064 $26.9 Million
Q4 2023 Feb 14, 2024	SELL	$36.74 - $81.08 $655,698 - $1.45 Million	-17,847 Reduced 3.33%	518,890 $41 Million
Q3 2023 Nov 14, 2023	SELL	$53.47 - $96.07 $4.06 Million - $7.29 Million	-75,876 Reduced 12.39%	536,737 $29.4 Million
Q2 2023 Aug 14, 2023	SELL	$66.23 - $88.73 $1.12 Million - $1.5 Million	-16,871 Reduced 2.68%	612,613 $51.4 Million
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $2.82 Million - $4.33 Million	-52,574 Reduced 7.71%	629,484 $47.7 Million
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $1.1 Million - $1.82 Million	28,244 Added 4.32%	682,058 $42.1 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $2.33 Million - $4.12 Million	73,927 Added 12.75%	653,814 $27.3 Million
Q2 2022 Aug 11, 2022	SELL	$20.56 - $32.15 $23,479 - $36,715	-1,142 Reduced 0.2%	579,887 $18.2 Million
Q3 2021 Nov 12, 2021	SELL	$25.92 - $34.51 $3.86 Million - $5.14 Million	-148,960 Reduced 20.41%	581,029 $19.2 Million
Q2 2021 Aug 12, 2021	SELL	$21.63 - $40.07 $264,123 - $489,294	-12,211 Reduced 1.65%	729,989 $24.2 Million
Q1 2021 May 12, 2021	BUY	$17.75 - $47.82 $1.79 Million - $4.81 Million	100,588 Added 15.68%	742,200 $30.8 Million
Q4 2020 Feb 16, 2021	BUY	$11.91 - $19.9 $767,778 - $1.28 Million	64,465 Added 11.17%	641,612 $12.8 Million
Q3 2020 Nov 16, 2020	BUY	$13.78 - $18.84 $2.1 Million - $2.87 Million	152,147 Added 35.8%	577,147 $7.95 Million
Q2 2020 Aug 13, 2020	BUY	$11.66 - $18.26 $4.96 Million - $7.76 Million	425,000 New	425,000 $7.62 Million

Others Institutions Holding TMDX

# of Institutions

394

Shares Held

31.9M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.56B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Trans Medics Group, Inc. Transaction History